Peghin, Maddalena
Bontempo, Giulia
De Martino, Maria
Palese, Alvisa
Gerussi, Valentina
Graziano, Elena
Fabris, Martina
D’Aurizio, Federica
Sbrana, Francesco
Ripoli, Andrea
Curcio, Francesco
Isola, Miriam
Tascini, Carlo
Article History
Received: 28 February 2022
Revised: 20 September 2022
Accepted: 27 September 2022
First Online: 31 October 2022
Declarations
:
: This study was approved by the Ethics Committee of the Friuli Venezia Giulia Region (CORMOR 3–4 protocol; CEUR-2020-OS-219 and CEUR-2020-OS-205).All procedures were carried out in accordance with the ethical standards of the University of Udine and the Azienda Sanitaria Universitaria Friuli Centrale and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Patients gave their written consent prior the participation on the study and informed consent was obtained from all the participants.
: Not applicable.
: MP reports receiving grants and personal fees from Pfizer, MSD, Menarini and Dia Sorin outside the submitted work. CT has received grants in the last two years from Correvio, Biotest, Biomerieux, Gilead, Angelini, MSD, Pfizer, Thermofisher, Zambon, Shionogi, Avir Pharma and Hikma outside the submitted work. The other authors have no conflict of interest to declare.